Free tool
FAERS Monitor: Brisdelle
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 204516 or its brand name (Brisdelle, Paroxetine Mesylate). Reports on generic versions are filed under their own applications.
Reports
34,264
Serious
28,096
82% of reports
Hospitalization
13,566
Death reported
4,456
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective2,117
- drug interaction1,913
- fatigue1,894
- nausea1,790
- toxicity to various agents1,649
- diarrhoea1,527
- anxiety1,516
- headache1,499
- dizziness1,405
- off label use1,396
- fall1,328
- drug abuse1,299
- confusional state1,295
- somnolence1,260
- vomiting1,239
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 133 |
| 2005 | 108 |
| 2006 | 176 |
| 2007 | 519 |
| 2008 | 170 |
| 2009 | 193 |
| 2010 | 217 |
| 2011 | 297 |
| 2012 | 1,094 |
| 2013 | 1,236 |
| 2014 | 1,653 |
| 2015 | 2,273 |
| 2016 | 2,335 |
| 2017 | 2,281 |
| 2018 | 3,063 |
| 2019 | 3,446 |
| 2020 | 2,766 |
| 2021 | 2,356 |
| 2022 | 2,181 |
| 2023 | 2,090 |
| 2024 | 2,138 |
| 2025 | 2,001 |
| 2026 | 1,537 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,019,895 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| drug abuseSignal | 1,299 | 9.7 | 9.2 | 10,028 |
| drug interactionSignal | 1,913 | 7.5 | 7.2 | 10,684 |
| toxicity to various agentsSignal | 1,649 | 6.1 | 5.8 | 6,936 |
| confusional stateSignal | 1,295 | 5.0 | 4.7 | 4,078 |
| somnolenceSignal | 1,260 | 3.9 | 3.7 | 2,675 |
| anxietySignal | 1,516 | 3.3 | 3.1 | 2,423 |
| fallSignal | 1,328 | 2.5 | 2.3 | 1,158 |
| dizziness | 1,405 | 1.7 | 1.6 | 442 |
| vomiting | 1,239 | 1.6 | 1.5 | 299 |
| fatigue | 1,894 | 1.5 | 1.4 | 321 |
| headache | 1,499 | 1.5 | 1.4 | 230 |
| diarrhoea | 1,527 | 1.5 | 1.4 | 222 |
| nausea | 1,790 | 1.4 | 1.3 | 202 |
| drug ineffective | 2,117 | 1.0 | 0.9 | 0 |
| off label use | 1,396 | 1.0 | 0.9 | 1 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.